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HYPOPHYSIS AND BLOOD PRESSURE
BY BERNARDO A. HOUSSAY, M.D.\s=d\
IN 1894 Oliver and Schafer113 discovered thatpituitary extracts raised the blood pressure;
Howell78 showed that this action was due to
the posterior lobe; and in 1928 Kamm85 and his
collaborators separated the vasopressor and the
oxytocic principles.*. It came to be believed
early that the pituitary played an important
part in the regulation of the arterial pressure.105
Azam10 and Delille,44 a pupil of Renon, at-
tributed the lowered blood pressure, accelerated
pulse, etc., of acute infections to an insufficiency
of the pituitary, since treatment with the ex-
tract corrected these symptoms. Renon even
postulated a syndrome of hyperpituitarism with
hypertension and bradycardia. But in spite of
many theories there were few facts to support
them, and in 1932 Dale41 concluded that it was
not possible to say what part the vasopressor
principle in the posterior lobe played in the
maintenance of normal blood pressure. Never-
theless numerous experimental and clinical ob-
servations indicate that there may be a rela-
tion between the pituitary and the blood pres-
sure level. We will describe and discuss these
observations in this paper.




The toad's pituitary contains
substances which raise the blood pressure of
the dog,"-76 the cat61 and the toad.114 The
neuro-intermediate lobe is more active than the
principal lobe in this respect.114 The vascular
system of the batrachians is sensitive to the
vasopressor substance in the mammalian pitui-
taryi, i4,55,74,93,113,114,118, etc. but Hogben and
Schlapp09 had to use such large quantities to
produce effects, that it was not possible to con-
sider them physiological.
A few hours after complete extirpation of
the pituitary in the toad the capillaries and
arterioles of the skin become dilated.9'94 Injec-
tion or perfusion of pituitrin, even in doses of
1:1,000,000 re-establishes the capillary tone and
larger doses produce a contraction of the arteri-
oles as well. From these facts Krogh93 de-
duced that the pituitary, by means of a hor-
mone, had a continuous action on the tone of
the capillaries.J
 Extensive bibliographies on the vasopressor activity of
pituitary extracts will be found in Houssay,74 Geiling,", Tren-
delenburg.146 My own work on the subject will be found in
my book.74
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JKrogh also brings evidence for the presence of the hormone
in the blood of mammals. Thus, in ox serum there is a sub-
stance which constricts the capillaries; it is dialyzable, insoluble
in alcohol and ether, soluble in methyl alcohol and thermostable.
The removal of the principal lobe produces a
similar but transitory alteration,9,94 since the
normal tone is soon recovered,94 though in some
cases the recuperation may not be complete.9
In the toad when the nutritional disturbances
and asthenia are marked, usually about one
month after the lobectomy, the vasodilatation
again becomes pronounced. Infundibulotuberal
lesions produce only a moderate and passing
dilatation.9 The dilated capillaries are un-
stable,94 but react well to thermal stimuli.9 Ac-
cording to Nogaki,111 however, the contractile
capacity of the vascular system is reduced in
the hypophysectomized frog.
Blount23 produced a state of hyperpitui-
tarism in the larvae of Amblystoma, by grafting
two extrahypophyseal anlagen. In these ani-
mals he observed vasoconstriction, bradycardia,
hypertrophy of the ventricle, and sometimes
edema. The basal membrane of the glomeruli
of the kidney was thickened, the glomeruli were
diminished in size and in some the capillaries
became obstructed; these lesions are similar to
those seen in human hypertension.23
Orias has done important wrork in our Insti-
tute, showing that the intermedio-neural lobe
plays a considerable role in the maintenance of
normal blood pressure in the toad Bufo arena-
rum (Hensell). Removal of the principal lobe
alone did not alter the blood pressure until the
nutritional disturbances and neuromuscular
asthenia appeared, when it w7as found some-
what lower (30 mm. Hg.) than in the controls
which had only been craniotomized (39 mm.
Hg.). (Fig. 1.) When the whole pituitary was
removed, i.e., the neuro-intermediate together
with the principal lobe, the blood pressure be-
gan to fall within a few hours after the op-
eration. At times there was a transitory re-
action in about twenty-four hours, but after-
wards the decrease continued and an average
blood pressure of 24 mm. Hg. was found one
week after operation and of 17 mm. one month
later. The injection of extracts of either lobe
raised the blood pressure but the neuro-inter-
mediate was the more active. The fall in blood
pressure could be prevented by daily implanta-
tion of one lobe, either glandular or neuro-
intermediate. Neubach (unpublished data)
showed that intravenous injection of 3 cc. arte-
rial blood from a normal toad produced a sig-
nificantly greater increase in the blood pres-
sure of hypophysectomized toads than did the
same quantity of blood from hypophysectomized
toads.
Several facts indicate that the vasopressor
and melanophore dilating activities are due to
different substances. The following evidence
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may be so interpreted, namely, that after remov-
al of the pituitary the skin blanches before the
blood pressure drops; that there are certain dif-
ferences in the pharmacological and chemical
characteristics of the two hormones ;46,46,47,64,56,
etc- and, of even more significance, that Dietel45,46
has isolated a melanophore dilating substance
which, far from having a pressor effect, dilates
FIG. 1.
Blood pressure of toads in mm. Hg.
Eight days after operation.
1. Controls.
2. Removal of principal lobe.
3. Lesion of tuber cinereum.
4. Hypophysectomy.
5. Hypophysectomy and lesion of tuber cinereum.
6. Hypophysectomy and implantation of neuro-intermediate
lobe.
7. Hypophysectomy and implantation of principal lobe.
Thirty days after operation.
8. Controls.
9. Removal of principal lobe.
10. Hypophysectomy.
the capillaries and decreases the blood pres-
sure. He believes it may also have a part in




the blood pressure in twenty-five hypophysec-
FIG. 2.
Blood pressure of dogs in cm. Hg.
tomized dogs in our Institute. Only three of
the operated animals had a normal blood pres-
sure and the average value (108 mm. Hg.), was
lower than that found in twenty-one normal
controls (127 mm. Hg.). Lesions of the tuber
did not modify the blood pressure, the average
being 124 mm. Hg. in thirteen experiments, nor
did the removal of the posterior lobe produce
a significant decrease, the average being 120
mm. Hg. in four dogs. (Fig. 2.) It must be
noted that in these experiments the extirpations
were not complete, since the pars tuberalis re-
mained in the hypophysectomized animals, and
in those whose posterior lobe alone was removed,
fragments of the pars intermedia were left be-
hind."*
Braun Menendez25'26 was able to demonstrate
that the vasomotor reactions were less adequate
in the hypophysectomized than in normal dogs.
When dogs were bled from the carotid to the
extent of 1.5 per cent of the body weight the
blood pressure fell 30 to 40 mm. Hg. In six
experiments on normal animals the pressure
returned to its initial level in 25 to 75 (aver-
age 45) minutes, whereas in nine experiments
on hypophysectomized animals the initial pres-
sure was not re-established until 75 to 130 (av-
erage 95) minutes following bleeding. (Fig. 3.)
FIG. 3.
Graph showing the effect of hemorrhage on the blood pressure
of normal and hypophysectomized dogs.
Solid line-—average of five normal dogs.
Dotted line—average of nine hypophysectomized dogs.
At arrow the animals were bled from the carotid artery to the
extent of 1.5 per cent of the body weight.
Abscissae—Time in minutes.
Ordinates—cm. Hg.
In the rat, removal of the posterior lobe does
not alter the blood pressure significantly, the
observed pressures being within the normal
range, though somewhat low. Their sensitivity
to histamine also is not increased. On the other
hand complete hypophysectomy is followed by a
decrease in blood pressure and there may be a
lowered resistance to histamine.53 Yamashita154
also found a lowered blood pressure in the rab-
bit after partial hypophysectomy.
BLOOD PRESSURE IN HUMAN PITUITARY
INSUFFICIENCY
In patients with chromophobe adenomas of
the pituitary the systolic pressure is usually
low.11'36'71'116 Cushing36 found it to be below
*Before Braun Menendez did his work I had measured the
blood pressure in a hypophysectomized dog in 1921 and Koster
and Geesink90 did the same in two dogs. Braun Menendez used
Biasotti's method, which measures the systolic pressure.20
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100 mm. Hg. in 11 per cent and below 110 in
46 per cent of his 200 cases, while only two
had an abnormally high blood pressure. In
craniopharyngiomas it is lower still. Peremy120
found the blood pressure to be between 78 and
110 mm. Hg. in 20 out of 45 cases of hypophys-
eal tumor.
In many cases of pituitary cachexia there is
a low blood pressure, as noted in the papers
by Graubner,59 Calder30 and others more re-
cently. The vasomotor reactions are also dis-
turbed.13'2 After muscular exercise both the
systolic and diastolic pressures fall markedly,
and the same may happen when the patients re-
sume the erect posture after a period of reclin-
ing. This circulatory collapse frequently oc-
curs in such patients and may be corrected by
treatment with anterior lobe extract. Never-
theless it cannot be attributed specifically and
primarily to the hypophysis, since it is a com-
mon occurrence in other types of cases which
have a low blood pressure and marked loss of
weight. Thus, it has been seen in hypothyroid-
ism and in cases of tabes dorsalis. In spite of
this, Schelling believes that the pituitary an-
terior lobe is of importance in the regulation
of blood pressure. Ratner125 found these cir-
culatory disturbances in ten cases, and attrib-
utes them to adrenal insufficiency due to a de-
ficient secretion of the pituitary adrenotropic
hormone.
BLOOD PRESSURE IN ACROMEGALY
The postmortem examination of acromegalics
often reveals arteriosclerosis and enlargement
of the heart. Numerous instances of increased
blood pressure have been reported in these pa-
tients2, 8> S1, 32, 40, 63, 80" 108' 115, 117, 119, m> 122, 155
and death is frequently due to cardiac insuffi-
ciency. Nevertheless the pressure was low (be-
low 120 mm. Hg.) in 30 out of 100 cases of
acromegaly studied by Davidoff43 and in 28 per
cent of those seen by Rowe and Lawrence.129
According to Kylin,97 in cases of acromegaly oc-
curring in Sweden and collected by Brennig,
the blood pressure was normal in young sub-
jects, in only two was it above 140 mm. Hg.,
but in the patients forty or more years old 11
per cent of the men and 60 per cent of the
women had a high blood pressure. Henstell63
says that paroxysmal hypertension may occur
in acromegalics.
PITUITARY BASOPHILISM AND THE BLOOD PRESSURE
We owe to Cushing the recognition of a clini-
cal syndrome characterized by adiposity, dorso-
cervical kyphosis, amenorrhea or impotence, hy-
pertrichosis, plethoric skin with atrophic striae,
high blood pressure, glycosuria, osteoporosis, etc.
At autopsy a basophile adenoma of the pitui-
tary is found in a large proportion of the cases
in the literature which I have read. The raised
blood pressure was evident and constant in the
reports of seventeen cases confirmed by autopsy
and in which the blood pressure was re-
corded 3- 12, 22, 33' 35' 3S' 88, 98, 110' 126' 127, 130' 131, 141,
i5o, 151 gome 0f the literature I have not been
able to read16'68'142'etc- and in numerous pub-
lished cases there was no anatomical verifica-
tion.
Certain improvements which occur when the
pituitary is irradiated favor the theory that
it is the prime factor of this disease (Cushing,
Jamin, Dattner, Wohl and collaborators, Aub,etc.). Even though the basophile adenoma is
not constant (according to Bauer13 it was found
in only fifteen out of twenty-three cases) its
frequency is significant since in general it is a
rare condition, Susman140 finding it in only 3
per cent of the 260 pituitary glands which he
examined. In some cases adenoma was not pres-
ent but there was an increase in the basophile
cells; this is an equivalent pathological state
according to Cushing. In discussing the pos-
sible part the pituitary might take in the genesis
of raised blood pressure he considers that the
hypertension might be due (1) to a specific se-
cretion of the adenoma, (2) to stimulation of
the pressor secretion of the posterior lobe by
the adenoma, (3) to an action through some
other gland. Cushing38'39 is inclined to accept
the second of the possibilities just mentioned,
while Bauer13 maintains that elevation of pres-
sure is due to adrenal hyperactivity brought
about by the pituitary adrenotropic hormone,
Cushing39 observed that in cases of eclampsia
and elevated blood pressure and in certain
cases of basophilism with hypertension, there
was basophile cell infiltration of the posterior
lobe. This might indicate hyperactivity of this
lobe, but, according to Spark,137 this morpholog-
ical appearance has no significance. He made
an extensive study of reported cases and sec-
tioned the pituitary in seventy cases of raised
blood pressure, in eleven with a previous history
of raised blood pressure and in 108 where the
blood pressure was normal; in all types of
cases a similar basophilic infiltration was found.
Also Butt,28 in 200 cases, failed to find any cor-
relation between the degree of basophilic infil-
tration and the presence of arterial hyperten-
sion, arteriosclerosis, eclampsia or obesity. Onthe other hand an increase in the basophile
cells of the pituitary has been reported in eases
of raised blood pressure19,3V-93 and more fre-
quently in adiposity. Kraus91 found it in 8Q
per cent of cases of the latter type and believed
that the basophilism was secondary to the obes-
ity. In some cases of adrenal tumor the fact
that foci of basophile cells without ade-
noma18' 10°* have been found in the pituitary
*In these cases it may be supposed that pituitary basophilism
was the cause of the adrenal adenomas, which later became-malignant.
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has suggested the possibility that basophilism
may be secondary to overactivity of the adrenal.
Finally, Leyton104 found Cushing's syndrome
in a case of thymus tumor associated with
adrenal hyperplasia.
It is known that the presence of the anterior
pituitary is necessary for the development and
maintenance of the normal anatomical and func-
tional state of the adrenal cortex.75 Hypophy-
sectomy causes the atrophy of the reticular
layers and of the internal part of the fascicular
layers, with preservation or hypertrophy of the
glomerular zone, but leaves the medulla un-
changed. Adrenotropic extracts of the pituitary
may bring about the hypertrophy of the adrenal
cortex16,34,50'61,75, et0- and even produce small
adenomas123 and certain symptoms (adiposity,
bony alterations, etc.), which Thompson and
Cushing144 consider similar to those of basoph-
ilism. Up to now it has not been observed that
they cause a rise in blood pressure.
Bauer13 attributes the symptoms of Cush-
ing's syndrome to hyperactivity of the adrenal
cortex, due to an overproduction of the adreno-
tropic pituitary hormone. He refuses to accept
the theory that it originates in the basophile
cells, citing the frequency of basophilism in dif-
ferent circumstances and the fact that Sokolow
and Gromow'13*3 found a cortico-adrenal syn-
drome with raised blood pressure in a child,
which was found to have an eosinophile adenoma
of the pituitary. The anatomical state of a gland
does not give an adequate measure of its func-
tion; for this reason a possible overactivity of
the pituitary or the adrenal glands cannot be
excluded in those cases where no basophile ade-
noma or adrenal hypertrophy is found. It
would be necessary to measure the amount of
hormones secreted into the blood. Bauer13 fur-
ther draws attention to the fact that the symp-
toms of Cushing's syndrome are also those of
hyperactivity of the adrenals. In chromaffin
tumors of adrenal origin the blood pressure is
raised permanently or paroxysmally, and in
six eases in which the tumor was removed the
paroxysms disappeared. It has not been proved
that permanent hypertension is due to an ex-
cessive secretion of adrenin. Probably cortical
overactivity also causes the blood pressure to
rise, since there are cases of tumors of the
adrenal cortex with high blood pressure and
hyperglycemia and in some instances removal
of the tumor has cured these symptoms. It
must also be remembered that in certain cases
of Cushing's syndrome the adrenals are nor-
mal, although generally they are hypertrophied
or adenomatous.
The adrenal symptoms are predominant in
the syndrome of basophilism, but it cannot be
affirmed that the hyperactivity of the adrenalsis always of pituitary origin, although the large ,
number of typical and marked cases with baso-
phile adenoma of the pituitary is suggestive. It
can only be suspected that the latter is the pri-
mary cause in many cases. It is not yet clear
whether the raised blood pressure is due to an
excess of adrenal or pituitary hormones or -to
some other cause, since the presence of these
hormones in the blood has not yet been con-
firmed.
THE PITUITARY AND RAISED BLOOD PRESSURE IN THE
TOXEMIAS OF PREGNANCY AND IN ECLAMPSIA
Since Hofbauer's work66 it has been main-
tained that eclampsia may be due to a polyglan-
dular disturbance, with an excess of the pos-
terior pituitary lobe secretion predominating.The principal arguments brought forward and
some of the objections raised to them are as
follows: (1) There is a certain similarity be-
tween the symptoms of eclampsia and those
which are produced by posterior lobe ex-
tract,5, 49,52,66,95,102,128,147, etc- (e.g. tendency to
edema, raised blood pressure, capillary spasm,
convulsions and coma, pulmonary edema, ionic
changes, favorable action of narcotics), but
there are also definite differences.21, 14S (2)
There is a certain similarity between the ana-
tomical lesions found in eclampsia (in the liver,kidney, etc.) and those provoked by posterior
pituitary extract.52,89 However the majority
of writers consider these lesions rare and hardly
worth mentioning.* (3) The infiltration of- the
posterior lobe by basophile cells. in eclamptics
would cause oversecretion of pituitrin,39 but
Spark137 proved that the basophile invasion may
occur when eclampsia is not present. (4) Dialy-sis of the serum of eclamptics shows that
there is an increase in antidiuretic and blood
pressure raising substances5 but this cannot be
pituitary posterior lobe secretion (Theobald143).
The blood of eclamptics, when injected into
the cerebral ventricles, causes oliguria ac-
cording to Marx.106 The antidiuretic action,however, has not been confirmed in the careful
experiments of Byrom and Wilson29 or of Hur-
witz and Bullock.81 (5) The melanophore di-
lating substance is increased in the blood95 and
placenta49 of eclamptics. Against this are the
reports that the blood of eclamptics, in common
with that of normal or pregnant women, pos-
sesses the property of neutralizing the effectsof certain of the posterior pituitary lobe ex-
tracts, for example the oxytocic,53,145, etc- the
oliguric,21 the melanophore dilatory45 and the
pressor.134
THE PITUITARY AND OTHER HYPERTENSIONS
An increase of basophile cells has been seenin the hypophyses of two-thirds of the cases of
raised blood pressure,19 but is even more fre-
*For the older literature see Houssay74 and for the more
recent Ohligomacher112 and Scheps.133
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quent in obesity,91 and has also been observed
in other conditions. Spark137 declares that the
posterior pituitary lobe invasion by basophile
cells described by Cushing3*'39 can exist with
equal frequency when there is no raised blood
pressure.
Kylin97 believes that the anterior pituitary
lobe is an essential factor in hypertension, be-
cause the general and metabolic symptoms are
exactly opposite to those of pituitary insuffi-
ciency. Pal,116 and Merle and his collabora-
tors107 also believe in the pituitary theory and
Drouet48 describes improvement in certain cases
of raised blood pressure due to irradiation of
the pituitary. The cerebrospinal fluid of pa-
tients suffering from raised blood pressure only
occasionally contains "minute traces of pitui-
trin",79 so an overactivity of the posterior pi-
tuitary lobe does not seem to be an etiological
factor in the disease. Moehlig109 has produced
arteriosclerosis in rabbits, by submitting them
to a diet rich in fats and cholesterol combined
with treatment with pituitrin. Volhard148 has
shown that the raised blood pressure due to
ligature of the renal artery is produced both
in normal and hypophysectomized dogs.
PITUITARY, DIENCEPHALON AND HYPERTENSION
It has been known for some time* that the
principal vasomotor centres are in the medulla.
Section of the brain stem above the pons does
not modify the level of the blood pressure or
the vasomotor reflexes and reactions25,26,65,86,138,
139, etc. jn aeute experiments.
The stimulation of the posterior ventral part
of the hypothalamus causes a marked rise of
blood pressure,17,77,82,84,86,124,149 even in the
absence of the pituitary and adrenals. (Karplus
and Kreidl, confirmed in our Institute.) When
the adrenals are present there is also a marked
secretion of adrenin, itself capable of raising the
blood pressure77 and the blood sugar.82 The
melanophore dilating substance in the cerebro-
spinal fluid is also increased.87 Ergotamine or
the extirpation of the sympathetic chain and the
splanchnics82 suppresses the rise in blood pres-
sure. Leiter and Grinker101 affirm that the rise
in blood pressure occurs only when there aremuscular or respiratory disturbances, but de
Jaegher and Van Bogaert82 have shown that it
may be raised both by mechanical and chemical
stimuli which do not evoke muscular activity.According to Hoff and Urban67 lesions of the
mammillary bodies may cause a delayed rise inblood pressure some months after the operation.It has not been proved that the pituitary takes
part in the rise in blood pressure produced bycisternal injection of kaolin or other col-
loids.60, 61'70 Pituitrin causes a rise of blood pres-
sure if it is injected into the cerebrospinal
•For bibliography see Braun Menendez.2*
canal74,99 or the cistern.61, °2 If, however, it is
injected into the ventricles there is either a
fall in blood pressure followed by a rise37 or no
effect at all.63
GENERAL SUMMARY
The posterior pituitary lobe contains vaso-
pressor substances, which in amphibians play a
very important role in the maintenance of the
blood pressure and arterial and capillary tone.
Small quantities of similar substances exist in
the principal lobe of the toad, but removal of
this lobe causes a lowering of the blood pressure
only after asthenia has developed. In the rat,dog and man pituitary insufficiency is accom-
panied by lowered blood pressure; it is not clear
whether this is due to lack of one or both
lobes, but it seems more particularly due to
lack of the anterior lobe (central or peripheral
vascular asthenia).
The existence of raised blood pressure in
acromegaly has not been well established, since
the blood pressure is frequently normal in these
cases. On the other hand hypertension is a
constant and prominent symptom in the pitui-
tary basophilism syndrome of Cushing, thoughwhether this is due to pituitary or adrenal hy-persecretion or to a secondary or associated fac-
tor, is not yet clear.
The evidence put forward to demonstrate
that hyperactivity of the posterior pituitary lobeis the causal factor in eclampsia and in essen-tial hypertension is contradictory and inconclu-
sive.
In contradistinction to the medulla the di-
encephalon is not essential for the maintenance
of blood pressure in acute experiments, nor has
it been proved that increase in blood pressure
due to lesions or stimulation of this region isaccompanied by hypersecretion of the posterior
pituitary.
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MERCURIN SUPPOSITORIES AS A DIURETIC IN
THE TREATMENT OF EDEMA*
BY MARSHALL N. FULTON, M.D.\s=d\
IN the treatment of edema, particularly chronicor recurrent edema, diuretic drugs frequent-
ly are of great service. Of these the organic
mercurial salts have come to be used extensively
because of their effectiveness in increasing
urine output and their relative freedom from
toxic effects. Salyrgan (mersalyl) enjoys a
widespread popularity and has been found to
be effective even when given repeatedly over a
long period of time.1,2 During the past few
years another preparation, mercupurin, intro-
duced in Europe under the name of novurit,
combining both a mercurial salt and theophyl-
line, has been given enthusiastic recognition.3' 4-5
The disadvantages in the use of these drugs are
(1) that they must be given either by intrave-
nous or intramuscular injection, (2) that by
the former route they are liable to injure the
vein or surrounding tissues, and by intramus-
cular administration are irritating and painful
and (3) that their repeated use requires fre-
quent attendance of doctor to patient, or of
patient to doctor or clinic, which necessity often
curtails their employment. If either drug or
any other preparation equally effective could
be administered by the patient, himself, under
supervision, there would be a saving both in
time and money and added convenience of no
little measure.
It has been shown in certain European clinics
that the mercurial component of mercupurin, the
sodium salt of trimethylcyclopentane-dicarboxyl-
icacid-methoxy-mercuryhydroxide-allylamide, is
effective as a diuretic when administered by
rectum in suppository form.6'7-8 This prepara-
tion has recently been introduced in this coun-
try under the name of mercurin suppositories.
During the past eight months at the Peter Bent
Brigham Hospital we have had the opportunity
of using mercurin suppositories in twenty-five
patients with edema.J They have been found
to be an effective and safe diuretic, producingresults comparable with those obtained by
*From the Medical Clinic, Peter Bent Brigham Hospital,Boston, Mass.
\s=d\Fulton, Marshall N.\p=m-\Physician, Peter Bent Brigham Hos-pital. For record and address of author see "This Week's
Issue," page 1107.
tWe wish to express our thanks to the Camphell Products,Inc., 79 Madison Avenue, New York, N. Y., for the suppositories
msed in this work.
the intravenous injection of salyrgan or mer-cupurin. These results are published with the
feeling that this preparation offers a distinct
advance in diuretic therapy, particularly inthe convenience it affords to both doctor and
patient.
PLAN OF TREATMENT
All but five of the patients with whom this
report deals had cardiac failure with edema.
Most of them were observed for a time at bed
rest on the hospital wards. Following a periodof several days' observation to allow for ade-
quate digitalization or a spontaneous diuresis,they were given one gram of ammonium chlo-
ride three or four times a day. This therapy,introduced by Keith and his associates9, hasbeen shown to enhance the action of mercurial
diuretics by the mild degree of acidosis which
it produces.10 After two to four days of thisregime, the patients were given the suppositories
usually the first thing in the morning following
a cleansing enema. Use of the suppositories or
other diuretics was repeated at intervals of four
to six days, the patients, meanwhile, continuing
on a daily dosage of three or four grams of
ammonium chloride.
Each suppository, made of cocoa butter base,
contains 500 milligrams of the mercurial saltof mercupurin (C^Ho-iOnNHgNa) without anyadded theophylline. This is approximately fivetimes the amount of mercury contained in one
cc. of mercupurin or salyrgan.
RESULTS
The diuretic response to the suppositories was
very satisfactory, comparing favorably with thatobserved after intravenous administration of
mercurial salts. The increased urine flow be-
gan in one to three hours after the suppository
was given and was passed, as a rule, by the endof twelve hours, so that the patients were not
kept awake the following night voiding urine.Occasionally the increased urine flow lasted
twenty-four hours or longer. That the absorp-tion of the material by the rectal mucosa may
occur very promptly was indicated by one pa-tient who had a bowel movement twenty minutesafter insertion of the suppository, yet who
The New England Journal of Medicine 
Downloaded from nejm.org at UNIV OF NC/ACQ SRVCS on July 17, 2016. For personal use only. No other uses without permission. 
 From the NEJM Archive. Copyright © 2009 Massachusetts Medical Society. All rights reserved. 
